Decision-IQ: Management of HER2-Positive Breast Cancer With Brain Metastases: A Case-Based Activity

Image

In this brief, case-based activity, meet a 42-year-old woman with a history of human epidermal growth factor 2 (HER2)-positive breast cancer that metastasized to the brain while she was receiving systemic therapy. As you move through this activity, you will be directed to useful resources to help you make clinical decisions about managing her systemic and intracranial disease. Receive insights from medical oncologist Carey Anders, MD, and neurosurgeon Peter Fecci, MD, PhD, about the systemic treatment of metastatic, HER2-positive breast cancer and the assessment and management of brain metastases.

Format
Online Publication
Cost
Complimentary
Credit
0.25 AMA PRA Category 1 Credit™

Carey Anders, MD 
Medical Director, DCI Center for Brain and Spine Metastasis 
Member, Breast Medical Oncology Group

Peter E. Fecci, MD, PhD 
Associate Professor, Neurosurgery 
Director, Duke Center for Brain and Spine Metastasis 
Residency Program Director, Neurosurgery